Clinical Trial Detail

NCT ID NCT03214666
Title GTB-3550 (CD16/IL-15/CD33) Tri-Specific Killer Engager (TriKE) for High Risk Heme Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GT Biopharma, Inc.
Indications

mast-cell leukemia

myeloid leukemia

acute myeloid leukemia

myelodysplastic syndrome

Therapies

GTB-3550 TriKE

Age Groups: adult senior

No variant requirements are available.